Refreshing results…
Transient Autoreactive PF4 and Antiphospholipid Antibodies in COVID-19 Vaccine Recipients
UploadDesmopressin for bleeding in non‐severe hemophilia A: Suboptimal use in a real‐world setting
Download from doi.orgEstimating incidence of venous thromboembolism in COVID‐19: Methodological considerations
Download from doi.orgDesmopressin testing in von Willebrand disease: Lowering the burden
Download from doi.orgJoint status of patients with nonsevere hemophilia A
UploadCaging the dragon: Research approach to COVID-19–related thrombosis
Download from doi.orgCriteria for low von willebrand factor diagnosis and risk score to predict future bleeding
Download from onlinelibrary.wiley.comThe association between desmopressin exposure, FVIII response and side effects
Download from onlinelibrary.wiley.comHow I manage pregnancy in carriers of hemophilia and patients with von Willebrand disease
Download from ashpublications.orgAcquired haemophilia A after alemtuzumab therapy
Download from api.wiley.comMissing publications? Search for publications with a matching author name.